Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.

The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.

EXIMIOUS is a project funded by the Horizon 2020 program that aims to study the exposome to understand its relationship with immune-mediated diseases.

Male patients with Chronic Obstructive Pulmonary Disease, smokers and asthmatics are associated with an increased presence of eosinophils in the blood.

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

The results have been published in The New England Journal of Medicine in an article with the participation of Dr. Antonio Álvarez, researcher of the Pneumology group.

Biopsies obtained by flexible bronchoscopy have been used to analyze which patients have sequelae in the lung in order to recommend, if necessary, the administration of corticosteroids as a treatment.

The funded project, led by Dr. Berta Sáez, will analyze the usefulness of certain biomarkers for the diagnosis and evaluation of disease progression.